Lindus Health and University of Oxford Publish Study Citing Key Strategies to Foster Diversity in Clinical Trial Participation
NEW YORK, May 2, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, announced the results of a study examining the motivators and deterrents of clinical trial participation among ethnic minorities. The research paper, published in MedRxiv, outlines strategies sponsors can utilize to minimize deterrents and promote diversity in their research.
- The research paper, published in MedRxiv , outlines strategies sponsors can utilize to minimize deterrents and promote diversity in their research.
- Lindus Health partnered with the University of Oxford in a collaborative effort to conduct a qualitative study aimed at investigating perceptions regarding participation in clinical research.
- The study collected data from both research professionals and the general population through eSurveys, meticulously crafted with guidance from the Enhancing Diversity in Clinical Trials (EDICT) advisory committee.
- The top three barriers to participation overall, regardless of study phase, included safety and health concerns, time investment, and lack of support.